A Transplant or Cancer Resilience Intervention

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Mayo Clinic
Information provided by (Responsible Party):
Cynthia M. Stonnington, M.D., Mayo Clinic
ClinicalTrials.gov Identifier:
First received: June 21, 2012
Last updated: January 9, 2014
Last verified: January 2014

The overall aim of this protocol is to examine patient and care-giver outcomes and acceptance of a new 6 week intervention in Arizona for our transplant and cancer patients and their care-givers, designed to improve quality of life, decrease perceived stress, and improve medical outcomes, that has been approved as a pilot clinical program at Mayo Clinic in Arizona.

Condition Intervention
Behavioral: Mindfulness based Resilience Training

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: A Resilience Intervention Involving Mindfulness Training for Transplant and Cancer Patients and Their Caregivers

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Patient questionaire [ Time Frame: baseline to 6 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 50
Study Start Date: September 2012
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Mindfulness based Resilience Training
    6 weekly group sessions

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient listed for liver, heart, kidney, or bone marrow transplant
  • Patient who has received a liver, heart, kidney, or bone marrow transplant
  • Caregiver of transplant patient
  • patient with diagnosis of cancer, either active or in remission
  • supportive care partner of cancer patient

Exclusion Criteria

  • Suicidal
  • Severe cognitive impairment
  • psychotic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01629069

United States, Arizona
Mayo Clinic in Arizona Recruiting
Scottsdale, Arizona, United States, 85259
Contact: Tisha Pathuis, LCSW    480-342-2161    pathuis.patricia@mayo.edu   
Contact: Cynthia M Stonnington, MD    480-301-4853    stonnington.cynthia@mayo.edu   
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: Cynthia Stonnington, MD Mayo Clinic
  More Information

No publications provided

Responsible Party: Cynthia M. Stonnington, M.D., Chair, Department of Psychiatry & Psychology, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01629069     History of Changes
Other Study ID Numbers: 12-004988
Study First Received: June 21, 2012
Last Updated: January 9, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:

ClinicalTrials.gov processed this record on September 16, 2014